Πέμπτη 25 Οκτωβρίου 2018

Contribution of the GSTP1 c.313A & gt;G variant to hearing loss risk in patients exposed to platin chemotherapy during childhood

ConclusionTheGSTP1 c.313A>G variant may increase the risk of low-frequency HL in pediatric oncology patients treated with cisplatin or carboplatin chemotherapy. (Source: Clinical and Translational Oncology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2OMKRV4

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.